Maia Biotechnology Inc
General ticker "MAIA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $50.2M
Maia Biotechnology Inc follows the US Stock Market performance with the rate: 27.1%.
Estimated limits based on current volatility of 6.4%: low 1.92$, high 2.19$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.50$, 1.88$]
- 2024-12-30 to 2025-12-30 estimated range: [0.48$, 1.71$]
Short-term MAIA quotes
Long-term MAIA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.41MM | $0.00MM |
| Operating Expenses | $7.79MM | $16.58MM | $20.18MM |
| Operating Income | $-7.79MM | $-16.18MM | $-20.18MM |
| Non-Operating Income | $-4.74MM | $-0.22MM | $0.41MM |
| Interest Expense | $0.83MM | $0.01MM | $0.00MM |
| R&D Expense | $3.45MM | $8.62MM | $11.11MM |
| Income(Loss) | $-12.53MM | $-16.40MM | $-19.77MM |
| Profit(Loss) | $-12.53MM | $-16.40MM | $-19.77MM |
| Stockholders Equity | $9.18MM | $8.51MM | $0.48MM |
| Inventory | $0.04MM | $0.00MM | $0.00MM |
| Assets | $11.33MM | $12.02MM | $7.57MM |
| Operating Cash Flow | $-4.12MM | $-11.66MM | $-13.07MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.00MM | $0.00MM |
| Financing Cash Flow | $14.03MM | $12.04MM | $9.27MM |
| Earnings Per Share* | $-1.25 | $-1.70 | $-1.49 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.